Results 131 to 140 of about 2,997 (148)

Effectiveness and Safety of Glycopyrronium-Formoterol-Budesonide Triple Therapy in Chronic Obstructive Pulmonary Disease (AIR-FORCE): An Open-Label Multi-Centric Phase 4 Study. [PDF]

Adv Respir Med
Nath AR, Kumar A, Bhate AS, Mehrotra B, Rai DK, Barge VK, Bhojwani D, Bhagat S, Bhushan S, Patil S, Barkate H.   +10 more
europepmc   +1 more source

Effects of Glycopyrronium Bromide as an Adjuvant Treatment in the Prevention of Nausea and Vomiting After Abdominal, Thyroid, and Breast Surgery: A Multicenter Randomized Controlled Trial. [PDF]

Drug Des Devel Ther
Chen J, Piao G, Luan G, Yu Y, Zheng W, Li Y, Zhang C, Duan Y, Zhao M, Zhang Y, Xiang W, Cheng L, Ji C, Duan G, Huang H.   +14 more
europepmc   +1 more source

Cost-effectiveness modeling of mortality risk reduction comparing two fixed-dose combination triple therapies in moderate-to-very severe chronic obstructive pulmonary disease. [PDF]

J Comp Eff Res
Parsekar K, Pandey S, Tansey-Dwyer D, Marshall J, Rustignoli I, Pollack M, Singh B, Ouwens M.   +7 more
europepmc   +1 more source

Bioequivalence of budesonide/glycopyrrolate/formoterol fumarate with a next-generation propellant versus hydrofluoroalkane-134a in healthy adults: phase I, randomized, double-blind, single-dose, partial-replicate, three-way cross-over lung exposure and total systemic exposure studies. [PDF]

Ther Adv Respir Dis
Bednarczyk A, Aurivillius M, Jassal M, Shah M, Raphiou I, Petullo D, Xu J, Heijer M, Sychowicz K, Collison K, Silva C, Reddy J, Han D, Goldwater R, Gillen M, Patel M.   +15 more
europepmc   +1 more source

Comparative In Vitro Deposition Analysis of Formoterol, Glycopyrronium, and Tiotropium Delivered via Capsule-Based DPI. [PDF]

Pharmaceutics
Sikora A, Chałupka J, Lewandowska K, Drapińska P, Marszałł MP.   +4 more
europepmc   +1 more source

Primary Hyperhidrosis: A Review of Epidemiology, Pathophysiology and Management. [PDF]

Acta Derm Venereol
Shayesteh A.
europepmc   +1 more source

An Open-Label, Single-Arm, Multicentric, Prospective, Phase IV Study to Evaluate the Safety and Effectiveness of Indacaterol/Mometasone/Glycopyrronium Dry Powder Inhaler (DPI) in the Management of Asthma Patients (OASIS Study). [PDF]

Cureus
Karmakar S, Bhate SG, Barge VB, Kumar VK, Nath AR, Sinha E, Bhagat S, Patil S, Bhushan S, Gadkari R, Barkate H.   +10 more
europepmc   +1 more source

Efficacy, pharmacokinetics, and safety of nebulized HL231 inhalation solution in patients with chronic obstructive pulmonary disease: a randomized trial. [PDF]

J Thorac Dis
Hu Q, Zhao L, Yang G, Wen F, Xie L, Xiao Z, Chen F, He Q, Bian T, Xiong H, Li F, Yue Y, Li Y, Luo L, Luo Z.   +14 more
europepmc   +1 more source

A multicentre, observational prospective study to characterise the use of inhaled triple therapy for COPD: TETRIS final results after a 24-month follow-up period. [PDF]

Ther Adv Respir Dis
Vogelmeier CF, Claussen J, Beeh KM, Kardos P, Watz H, Westermayer B, Rohde G.   +6 more
europepmc   +1 more source